We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YYAI:NASDAQAiRWA Inc. Analysis

Data as of 2026-05-28 - not real-time

$10.83

Latest Price

8/10Risk

Risk Level: High

Executive Summary

AiRWA Inc. (YYAI) is trading well below its short‑term moving averages, with the price under the 20‑day and 50‑day SMA, and the RSI indicates a deep oversold condition. Technical indicators such as a bearish MACD histogram and a negative MACD crossover reinforce a downward momentum, while the stock’s beta exceeds 2.5, pointing to heightened sensitivity to market swings. Volatility is extreme, reflected in a 30‑day price swing of over 170% and a near‑total historic drawdown, compounded by a market cap of just over $11 million and very low average volume, which together create a pronounced liquidity risk. The recent announcement of a 1‑for‑40 reverse split adds procedural uncertainty that could further affect short‑term price stability. Despite these pressures, the discounted cash‑flow model suggests a fair value far above the current price, implying a substantial valuation gap. However, fundamental metrics reveal negative operating and profit margins, negligible return on equity, and a reliance on cash rather than earnings, which tempers the upside narrative. In the context of a technology‑infrastructure sector that is generally growth‑oriented but also faces regulatory scrutiny around AI and data privacy, the stock presents a classic high‑risk, high‑potential scenario. Investors should weigh the stark technical weakness and liquidity constraints against the long‑term valuation upside and the company’s modest revenue growth trajectory.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below key moving averages and deep oversold RSI
  • Bearish MACD and high beta indicating strong downside pressure
  • Liquidity constraints and upcoming reverse split uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Modest revenue growth despite negative margins
  • Potential stabilization after reverse split execution

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to intrinsic DCF estimate
  • Long‑term AI and matchmaking market expansion prospects
  • Opportunity to capitalize on price recovery if liquidity improves

Key Metrics & Analysis

Financial Health

Revenue Growth113.10%
Profit Margin-3.54%
P/E Ratio0.0
ROE0.01%
ROA0.68%
Debt/Equity0.42
P/B Ratio2.4
Op. Cash Flow$3.4M
Free Cash Flow$5.5M
Industry P/E40.7

Technical Analysis

TrendBearish
RSI21.5
Support$10.00
Resistance$31.44
MA 20$21.26
MA 50$30.19
MA 200$1,209.65
MACDBearish
VolumeIncreasing
Fear & Greed Index92.57

Valuation

Fair Value$227.04
GradeUndervalued
TypeValue

Risk Assessment

Beta2.54
Volatility171.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.